Armata Pharmaceuticals's total assets for Q2 2025 were $80.79M, a decrease of -7.40% from the previous quarter. ARMP total liabilities were $150.29M for the fiscal quarter, a 6.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.